Oncología Traslacional
ONCTRAS
Hospital Universitario Marqués de Valdecilla
Santander, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Marqués de Valdecilla (22)
2024
-
Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/ MINOVA Study)
Clinical Cancer Research, Vol. 30, Núm. 1, pp. 176-186
2023
-
ASO Visual Abstract: Accuracy and Survival Outcomes After National Implementation of Sentinel Lymph Node Biopsy in Early-Stage Endometrial Cancer
Annals of surgical oncology, Vol. 30, Núm. 12, pp. 7669-7670
-
Accuracy and Survival Outcomes after National Implementation of Sentinel Lymph Node Biopsy in Early Stage Endometrial Cancer
Annals of Surgical Oncology, Vol. 30, Núm. 12, pp. 7653-7662
-
Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme
European Journal of Cancer, Vol. 182, pp. 3-14
2022
2021
-
Elective Cancer Surgery in COVID-19-Free Surgical Pathways during the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study
Journal of Clinical Oncology, Vol. 39, Núm. 1, pp. 66-78
-
Management of advanced ovarian cancer in Spain: an expert Delphi consensus
Journal of Ovarian Research, Vol. 14, Núm. 1
2019
-
Efficacy and safety results from GEICO 1205, a randomized phase II trial of neoadjuvant chemotherapy with or without bevacizumab for advanced epithelial ovarian cancer
International Journal of Gynecological Cancer, Vol. 29, Núm. 6, pp. 1050-1056
2017
-
A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM)
Clinical and Translational Oncology, Vol. 19, Núm. 5, pp. 616-624
2016
-
Epigenetic alterations leading to TMPRSS4 promoter hypomethylation and protein overexpression predict poor prognosis in squamous lung cancer patients
Oncotarget, Vol. 7, Núm. 16, pp. 22752-22769
2015
-
ABCB1 (MDR-1) pharmacogenetics of tacrolimus in renal transplanted patients: A Next Generation Sequencing approach
Clinical Chemistry and Laboratory Medicine, Vol. 53, Núm. 10, pp. 1515-1519
-
SEOM guidelines for cervical cancer
Clinical and Translational Oncology, Vol. 17, Núm. 12, pp. 1036-1042
2013
-
GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012
Clinical and Translational Oncology, Vol. 15, Núm. 7, pp. 509-525
2012
-
Association between a common KCNJ11 polymorphism (rs5219) and new-onset posttransplant diabetes in patients treated with Tacrolimus
Molecular Genetics and Metabolism, Vol. 105, Núm. 3, pp. 525-527
-
Identification of novel deregulated RNA metabolism-related genes in non-small cell lung cancer
PLoS ONE, Vol. 7, Núm. 8
2011
-
Erratum: Pharmacogenetics of tacrolimus after renal transplantation: Analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes (Clinical Chemistry and Laboratory Medicine (2011) 49:5 (825-833))
Clinical Chemistry and Laboratory Medicine
-
Feasibility of a modified outpatient regimen of intravenous/intraperitoneal chemotherapy in optimally debulked stage III ovarian cancer patients A GEICO study
International Journal of Gynecological Cancer, Vol. 21, Núm. 6, pp. 1048-1055
-
KCNQ1 gene variants and risk of new-onset diabetes in tacrolimus-treated renal-transplanted patients
Clinical Transplantation, Vol. 25, Núm. 3
-
Pharmacogenetics of tacrolimus after renal transplantation: Analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes
Clinical Chemistry and Laboratory Medicine, Vol. 49, Núm. 5, pp. 825-833